MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$391,764
Net Income
-$1,431,713
Net Profit Margin
-365.45%
EPS
-$0.75
Unit: Dollar
Revenue Breakdown
    • Gross sales

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net sales
391,764 472,982 425,864 503,612
Cost of sales
154,739 205,166 171,401 200,954
Gross profit
237,025 267,816 254,463 302,658
Selling and marketing
270,637 438,456 358,535 345,505
Research and development
55,488 135,377 227,993 228,606
General and administrative
1,224,354 1,948,913 1,122,684 1,564,967
Depreciation and amortization of intangible assets
15,038 16,271 16,268 22,184
Total operating expenses
1,565,517 2,539,017 1,725,480 2,161,262
Loss from operations
-1,328,492 -2,271,201 -1,471,017 -1,858,604
Other income
860 150,613 7,299 4,357
Interest expense
3,450 5,601 5,059 2,561
Amortization of debt discount
NaN 0* 0 0
Loss on forward purchase agreement
NaN 0* 0 0
Change in fair value of earnout liabilities
-96,053 -64,873* -86,104 29,630
Loss on lease termination
NaN 0* 0 NaN
Inventory write-down
196,684 -14,356* 47,082 NaN
Total other income (expense)
-103,221 224,241 41,262 -27,834
Loss from continuing operations before income taxes
-1,431,713 -2,046,960 -1,429,755 -1,886,438
Income tax expense
0 36,262 0 0
Loss from continuing operations
NaN -2,083,222 -1,429,755 -1,886,438
Loss from discontinued operations, net of tax
NaN 0* 0 0
Gain on sale of discontinued operations
NaN 0* 0 0
Net loss
-1,431,713 -2,083,222 -1,429,755 -1,886,438
Basic EPS
-0.75 -1.457 -0.83 -1.56
Diluted EPS
-0.75 -1.457 -0.83 -1.56
Basic Average Shares
1,899,910 1,429,557* 1,723,434 1,209,809
Diluted Average Shares
1,899,910 1,429,557* 1,723,434 1,209,809
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$1,431,713 (4.92%↑ Y/Y)Gross sales$424,390 (-20.67%↓ Y/Y)Loss from continuingoperations before income...-$1,431,713 (4.92%↑ Y/Y)Net sales$391,764 (-23.24%↓ Y/Y)Discounts and allowances-$32,626 (-32.68%↓ Y/Y)Loss from operations-$1,328,492 (11.83%↑ Y/Y)Total other income(expense)-$103,221 (-11776.58%↓ Y/Y)Gross profit$237,025 (-12.16%↓ Y/Y)Change in fair value ofearnout liabilities-$96,053 Cost of sales$154,739 (-35.67%↓ Y/Y)Other income$860 (-85.37%↓ Y/Y)Total operatingexpenses$1,565,517 (-11.88%↓ Y/Y)Inventory write-down$196,684 Interest expense$3,450 (-30.90%↓ Y/Y)General andadministrative$1,224,354 (-3.98%↓ Y/Y)Selling and marketing$270,637 (-3.53%↓ Y/Y)Research and development$55,488 (-71.82%↓ Y/Y)Depreciation andamortization of intangible...$15,038 (-37.22%↓ Y/Y)

Longevity Health Holdings, Inc. (XAGE)

Longevity Health Holdings, Inc. (XAGE)